Metraipolis › archive › dc_0cb42fc0c694

Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics — Europe PMC PMID:41716960

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41716960
DOI
10.1002/mco2.70634
License (as archived)
solo-consultazione
Archived
2026-10-08T15:20:32.606Z
SHA-256 of the archived text
818a085ce988e53553fc7690d03695ff5ad6e8d28077620d69f1f41a0c96c4fa
Stable URL of this page
https://metraipolis.com/documento/dc_0cb42fc0c694

How to cite

Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics — Europe PMC PMID:41716960 — Europe PMC (en), https://europepmc.org/article/MED/41716960 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cb42fc0c694 (Metraipolis archive dc_0cb42fc0c694, sha256 818a085ce988e53553fc7690d03695ff5ad6e8d28077620d69f1f41a0c96c4fa)
BibTeX
@misc{dc0cb42fc0c694,
  title = {Spironolactone and Fibrosis in Heart Failure Risk: Machine Learning Analysis of HOMAGE Trial Plasma Proteomics — Europe PMC PMID:41716960},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41716960},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cb42fc0c694; sha256 818a085ce988e53553fc7690d03695ff5ad6e8d28077620d69f1f41a0c96c4fa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716960. Agents can read the archived copy with the MCP tool read_document.